133 related articles for article (PubMed ID: 30949999)
1. Is copeptin a new potential biomarker of insulin resistance in polycystic ovary syndrome?
Widecka J; Ozegowska K; Banaszewska B; Kazienko A; Safranow K; Branecka-Wozniak D; Pawelczyk L; Kurzawa R
Ginekol Pol; 2019; 90(3):115-121. PubMed ID: 30949999
[TBL] [Abstract][Full Text] [Related]
2. Copeptin, a surrogate marker for arginine vasopressin, is associated with cardiovascular risk in patients with polycystic ovary syndrome.
Karbek B; Ozbek M; Karakose M; Topaloglu O; Bozkurt NC; Cakır E; Aslan MS; Delibasi T
J Ovarian Res; 2014 Mar; 7():31. PubMed ID: 24628831
[TBL] [Abstract][Full Text] [Related]
3. Circulating levels of obestatin and copeptin in obese and nonobese women with polycystic ovary syndrome.
Taskin MI; Bulbul E; Adali E; Hismiogulları AA; Inceboz U
Eur J Obstet Gynecol Reprod Biol; 2015 Jun; 189():19-23. PubMed ID: 25837320
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the Efficacy of Sex Hormone-Binding Globulin in Insulin Resistance Assessment Based on HOMA-IR in Patients with PCOS.
Chen F; Liao Y; Chen M; Yin H; Chen G; Huang Q; Chen L; Yang X; Zhang W; Wang P; Yin G
Reprod Sci; 2021 Sep; 28(9):2504-2513. PubMed ID: 33721297
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of insulin resistance in Korean women with polycystic ovary syndrome according to various homeostasis model assessment for insulin resistance cutoff values.
Kim JJ; Hwang KR; Oh SH; Chae SJ; Yoon SH; Choi YM
Fertil Steril; 2019 Nov; 112(5):959-966.e1. PubMed ID: 31542165
[TBL] [Abstract][Full Text] [Related]
6. A case-control observational study of insulin resistance and metabolic syndrome among the four phenotypes of polycystic ovary syndrome based on Rotterdam criteria.
Jamil AS; Alalaf SK; Al-Tawil NG; Al-Shawaf T
Reprod Health; 2015 Jan; 12():7. PubMed ID: 25595199
[TBL] [Abstract][Full Text] [Related]
7. L:A ratio, Insulin resistance and metabolic risk in women with polycystic ovarian syndrome.
Gupta V; Mishra S; Mishra S; Gupta V
Diabetes Metab Syndr; 2017 Dec; 11 Suppl 2():S697-S701. PubMed ID: 28529126
[TBL] [Abstract][Full Text] [Related]
8. Atrial natriuretic peptide, copeptin and adrenomedullin levels in polycystic ovary syndrome: a case-control study.
Frøssing S; Nylander M; Aziz M; Skouby SO; Kistorp C; Faber J
Gynecol Endocrinol; 2017 Jan; 33(1):30-33. PubMed ID: 27424881
[TBL] [Abstract][Full Text] [Related]
9. Diverse impacts of aging on insulin resistance in lean and obese women with polycystic ovary syndrome: evidence from 1345 women with the syndrome.
Livadas S; Kollias A; Panidis D; Diamanti-Kandarakis E
Eur J Endocrinol; 2014 Sep; 171(3):301-9. PubMed ID: 25053727
[TBL] [Abstract][Full Text] [Related]
10. Elevated circulating levels of xenopsin-related peptide-1 are associated with polycystic ovary syndrome.
Temur M; Özün Özbay P; Aksun S; Yilmaz Ö; Çift T; Üstünel S; Calan M
Arch Gynecol Obstet; 2017 Oct; 296(4):841-846. PubMed ID: 28831586
[TBL] [Abstract][Full Text] [Related]
11. Adrenomedullin: possible predictor of insulin resistance in women with polycystic ovary syndrome.
Sahin I; Celik O; Celik N; Keskin L; Dogru A; Dogru I; Yürekli M; Yologlu S
J Endocrinol Invest; 2012 Jun; 35(6):553-6. PubMed ID: 21791966
[TBL] [Abstract][Full Text] [Related]
12. Copeptin and insulin resistance: effect modification by age and 11 β-HSD2 activity in a population-based study.
Canivell S; Mohaupt M; Ackermann D; Pruijm M; Guessous I; Ehret G; Escher G; Pechère-Bertschi A; Vogt B; Devuyst O; Burnier M; Martin PY; Ponte B; Bochud M
J Endocrinol Invest; 2018 Jul; 41(7):799-808. PubMed ID: 29235050
[TBL] [Abstract][Full Text] [Related]
13. Serum Fetuin-A levels are increased and associated with insulin resistance in women with polycystic ovary syndrome.
Liu S; Hu W; He Y; Li L; Liu H; Gao L; Yang G; Liao X
BMC Endocr Disord; 2020 May; 20(1):67. PubMed ID: 32429902
[TBL] [Abstract][Full Text] [Related]
14. The correlation of plasma omentin-1 with insulin resistance in non-obese polycystic ovary syndrome.
Yang HY; Ma Y; Lu XH; Liang XH; Suo YJ; Huang ZX; Lu DC; Qin YF; Luo ZJ
Ann Endocrinol (Paris); 2015 Oct; 76(5):620-7. PubMed ID: 26514948
[TBL] [Abstract][Full Text] [Related]
15. Lipid accumulation product and insulin resistance in Iranian PCOS prevalence study.
Hosseinpanah F; Barzin M; Erfani H; Serahati S; Ramezani Tehrani F; Azizi F
Clin Endocrinol (Oxf); 2014 Jul; 81(1):52-7. PubMed ID: 23844634
[TBL] [Abstract][Full Text] [Related]
16. Assessment of insulin resistance in lean women with polycystic ovary syndrome.
Morciano A; Romani F; Sagnella F; Scarinci E; Palla C; Moro F; Tropea A; Policola C; Della Casa S; Guido M; Lanzone A; Apa R
Fertil Steril; 2014 Jul; 102(1):250-256.e3. PubMed ID: 24825420
[TBL] [Abstract][Full Text] [Related]
17. Increased circulating urocortin-3 levels is associated with polycystic ovary syndrome.
Temur M; Yilmaz Ö; Aksun S; Özün Özbay P; Calan M; Küme T; Karakulak M; Korkmaz HA
Gynecol Endocrinol; 2016; 32(3):218-22. PubMed ID: 26488073
[TBL] [Abstract][Full Text] [Related]
18. [Activity and distribution of plasma platelet-activating factor acetylhydrolase in polycystic ovary syndrome patients with insulin resistance].
Wan DH; Fan P; Bai H; Song Q; Liu HW
Zhonghua Fu Chan Ke Za Zhi; 2010 Jan; 45(1):30-4. PubMed ID: 20367923
[TBL] [Abstract][Full Text] [Related]
19. Neck circumference is a good predictor for insulin resistance in women with polycystic ovary syndrome.
Chen Y; Zheng X; Ma D; Zheng S; Han Y; Su W; Liu W; Xiao F; Lin M; Yan X; Zhao T; Liu C
Fertil Steril; 2021 Mar; 115(3):753-760. PubMed ID: 32917381
[TBL] [Abstract][Full Text] [Related]
20. Afamin serum concentrations are associated with insulin resistance and metabolic syndrome in polycystic ovary syndrome.
Seeber B; Morandell E; Lunger F; Wildt L; Dieplinger H
Reprod Biol Endocrinol; 2014 Sep; 12():88. PubMed ID: 25208973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
